Glucocorticoid drugs are synthetic versions of glucocorticoids; steroids that are naturally occurring compounds in the body. These have several functions.
Glucocorticoid Drugs: Introduction
- Glucocorticoid drugs are synthetic versions of glucocorticoids; steroids that are naturally occurring compounds in the body. These have several functions. These drugs interrupt inflammation by moving into cells and suppressing the proteins that go on to promote inflammation. These also help the body respond to stress and regulate body metabolism.
- Glucocorticoids are the first line of treatment for the management of any sort of adrenal insufficiency. The medication form of glucocorticoids such as hydrocortisone and other glucocorticoids (dexamethasone and prednisone) is recommended as a lifetime hormone replacement therapy for otherwise impaired cortisol levels.
- Glucocorticoid drugs available in the market are betamethasone, cortisone, dexamethasone, hydrocortisone, methylprednisolone, prednisolone, prednisone, and triamcinolone
- Glucocorticoid drugs are used to treat several disorders including autoimmune disorders, allergies & asthma, adrenal insufficiency, heart failure, cancer, and skin conditions
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78062
Key Drivers and Restraints of Global Glucocorticoid Drugs Market
- The number of patients affected with chronic diseases is rising across the world. Increase in incidence of chronic diseases of the liver, heart, kidneys, and pancreas; and blood disorders, have augmented the demand for glucocorticoids.
- Increase in the incidence of chronic diseases and rise in the geriatric population across the globe drive the global glucocorticoid drugs market
- Surge in health care expenditure, rise in global per capita income, and improvement in health care infrastructure & government reimbursement programs in developed as well as developing countries are projected to propel the global glucocorticoid drugs market in the near future
- Glucocorticoids may sound like miracle drugs, but these do have side effects. Some of them are critical and quite damaging. Hence, these drugs are not prescribed for long-term use. Side effects of these drugs include increase in blood sugar level, rise in cholesterol & triglyceride levels, surge in risk of ulcers & gastritis, and suppression of immune system. Long-term use could cause weight gain, diabetes, acne, depression, and fatigue. Therefore, side effects associated with the use of glucocorticoids are likely to hamper the growth of the global market.
Request for Analysis of COVID-19 Impact on Glucocorticoid Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78062
Allergies & Asthma to Lead Global Market
- The global glucocorticoid drugs market can be segmented based on drug type, indication, distribution channel, and region
- In terms of drug type, the global glucocorticoid drugs market can be divided into betamethasone, cortisone, dexamethasone, hydrocortisone, methylprednisolone, prednisolone, prednisone, triamcinolone, and others
- Based on indication, the global market can be categorized into allergies & asthma, arthritis, autoimmune disorders (multiple sclerosis, rheumatoid arthritis, etc.), cancer, postoperative inflammation, psoriasis, skin disorders, ulcerative colitis, and others
- In terms of end-user, the global glucocorticoid drugs market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies
Pre Book Glucocorticoid Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=78062<ype=S
Asia Pacific to be Lucrative Market
- The global glucocorticoid drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- Improving health care infrastructure, rise in awareness about timely diagnosis of underlying disorders, and large undiagnosed patient population are anticipated to present significant opportunities in the glucocorticoid drugs market in Asia Pacific in the near future.
Read more information here:
https://www.transparencymarketresearch.com/glucocorticoid-drugs-market.html
Key Players Operating in Global Glucocorticoid Drugs Market
Leading players in the global glucocorticoid drugs market are:
- GlaxoSmithKline plc
- Pfizer, Inc.
- Sanofi
- AstraZeneca plc
- Novartis International AG
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453